Nurse diabetes case management interventions and blood glucose control: results of a meta-analysis

Diabetes Research and Clinical Practice
Garry WelchRobert A Gabbay

Abstract

We conducted a meta-analysis of studies reporting diabetes case management interventions to examine the impact of case management on blood glucose control (HbA1c). Databases used for the search included Medline, PubMed, Cochrane EPOC, Cumulative Index to Nursing & Allied Health Literature database guide (CINAHL), and PsychInfo. A composite estimate of effect size was calculated using a random effects model and subgroup analyses were conducted. Twenty-nine salient studies involving 9397 patients had sufficient data for analysis. Mean patient age was 63.2 years, 49% were male, and ethnicity/race was 54% White. Type 2 diabetes was the focus in 91% of studies. Results showed a large overall effect size favoring case management intervention over controls or baseline values on HbA1c (ES=0.86, 95%CI: 0.52-1.19, Z=5.0, p<0.001). This corresponds to a mean HbA1c reduction of 0.89 (95%CI: 0.63-1.15). Subgroup analyses showed clinical setting, team composition, and baseline HbA1c were important predictors of effect size, but not diabetes self-management education which was poorly described or absent in most diabetes case management interventions examined. Nurse-led case management provides an effective clinical strategy for poorly control...Continue Reading

References

Mar 1, 1992·Journal of Clinical Epidemiology·A S DetskyK A L'Abbé
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Oct 1, 1996·Archives of Family Medicine·P J O'ConnorS Lasch
Nov 6, 2001·Annals of Internal Medicine·L S PhillipsC S Barnes
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Aug 6, 2002·Diabetes Research and Clinical Practice·Irl B HirschAllen D Cheadle
Mar 6, 2003·Yonsei Medical Journal·Jeong-Ah OhEuy-Soon Choi
Jul 29, 2003·Diabetes Care·Mayer B Davidson
Dec 4, 2003·Journal of Advanced Nursing·Hee-Seung Kim, Jeong-Ah Oh
Dec 23, 2003·The Journal of Clinical Hypertension·Henry R Black
May 18, 2004·The American Journal of Medicine·Sarah L KreinRodney A Hayward
Sep 18, 2004·Journal of the American Pharmacists Association : JAPhA·Carol L ArmourInes Krass
Nov 16, 2004·The American Journal of Medicine·Michael A SteinmanMary K Goldstein
Jun 29, 2005·Diabetes Care·Graham T McMahonPaul R Conlin
Jul 16, 2005·Diabetes Research and Clinical Practice·Robert A GabbayRosemary C Polomano
Oct 14, 2005·Journal of the American Medical Informatics Association : JAMIA·Steven SheaRafael A Lantigua
Apr 6, 2006·Annals of Internal Medicine·Jinan B SaaddineK M Venkat Narayan
Jul 27, 2006·JAMA : the Journal of the American Medical Association·Kaveh G ShojaniaDouglas K Owens
Dec 29, 2006·Diabetes Care·Carolé MensingCynthia Adams
Aug 2, 2007·Diabetes Care·Mark Peyrot, Richard R Rubin
Dec 7, 2007·The Diabetes Educator·Edwin B FisherRobert F Devellis

❮ Previous
Next ❯

Citations

May 14, 2014·International Journal of Nursing Practice·Soon Ae ShinGeorge Liu
May 16, 2014·Canadian Journal of Diabetes·Maureen ClementDiana Sherifali
Apr 5, 2015·International Journal of Nursing Studies·Xingjuan TaoFrances Kam Yuet Wong
Jan 13, 2015·Advances in Chronic Kidney Disease·Raquel Greer, L Ebony Boulware
Feb 23, 2018·International Journal of Clinical Pharmacy·Mangesh KharjulJames Green
Aug 23, 2019·PloS One·C John SperatiUNKNOWN National Kidney Foundation Education Committee
Apr 30, 2020·International Journal of Integrated Care·Patrick TimpelUNKNOWN MANAGE CARE Study Group
Dec 7, 2018·Diabetes/metabolism Research and Reviews·Hong JiJuan Zhou
Feb 28, 2021·American Journal of Preventive Medicine·Pâmela L S SteffenDaniel D Faustino-Silva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.